Roivant Sciences Ltd.'s Net Worth
$2.06 Billion
Who is Roivant Sciences Ltd.?
Roivant Sciences Ltd. has an estimated net worth of $2.06 Billion. This is based on reported shares across multiple companies, which include Health Sciences Acquisitions Corp, Urovant Sciences Ltd., Myovant Sciences Ltd., Axovant Sciences Ltd., and Arbutus Biopharma Corp.
SEC CIK
Roivant Sciences Ltd.'s CIK is 0001635088
Past Insider Trading and Trends
2019 was Roivant Sciences Ltd.'s most active year for acquiring shares with 41 total transactions. Roivant Sciences Ltd.'s most active month to acquire stocks was the month of May. 2021 was Roivant Sciences Ltd.'s most active year for disposing of shares, totalling 1 transactions. Roivant Sciences Ltd.'s most active month to dispose stocks was the month of September. 2019 saw Roivant Sciences Ltd. paying a total of $464,420,505.98 for 50,420,225 shares, this is the most they've acquired in one year. In 2021 Roivant Sciences Ltd. cashed out on 1,164,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Immunovant, Inc. (IMVT) Snapshot price: $34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.13% | 6M |
$38.00 | $228,000,000.00 | 79.81M |
Oct 2
| |||
Form 4
| +0.57% | 416.67K |
$6.00 | $2,500,002.00 | 73.81M |
Oct 6
| |||
Form 4
| +30.20% | 17.02M |
—
|
—
| 73.39M |
Aug 2
| |||
Form 4
| +18.44% | 8.77M |
—
|
—
| 56.37M |
Sep 17
| |||
Form 4
| +0.80% | 380K |
$33.00 | $12,540,000.00 | 47.59M |
Sep 4
| |||
Form 4
| +22.83% | 8.77M |
—
|
—
| 47.21M |
May 12
| |||
Form 4
| +2.77% | 1.03M |
$14.50 | $15,000,003.50 | 38.44M |
Apr 16
| |||
Form 4
| +7,612.36% | 36.92M |
$10.00 | $369,199,670.00 | 37.4M |
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.86M |
—
|
—
|
0
|
Dec 27
| |||
Form 4
| +0.08% | 18.2K |
$8.32 | $151,380.99 | 22.86M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.10% | 22.01K |
$8.06 | $177,300.64 | 22.84M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.09% | 21.34K |
$8.31 | $177,247.38 | 22.82M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.09% | 21.12K |
$7.86 | $165,950.15 | 22.8M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.08% | 17.75K |
$7.83 | $138,946.36 | 22.78M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.06% | 14.48K |
$7.63 | $110,461.18 | 22.76M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.09% | 19.83K |
$8.22 | $162,918.35 | 22.75M |
Scheduled
|
May 21 - May 23
| ||
Form 4
| +0.10% | 21.61K |
$7.54 | $162,884.29 | 22.73M |
May 16 - May 20
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -45.01M |
—
|
—
|
0
|
Dec 27
| |||
Form 4
| +0.55% | 245K |
$15.38 | $3,767,705.89 | 45.01M |
Dec 16 - Dec 17
| |||
Form 4
| +0.57% | 254.19K |
$18.03 | $4,584,355.61 | 44.76M |
Dec 2 - Dec 4
| |||
Form 4
| +8.53% | 3.5M |
$15.00 | $52,500,000.00 | 44.51M |
Nov 25
| |||
Form 4
| +0.60% | 243.81K |
$12.39 | $3,021,688.14 | 41.01M |
Nov 20 - Nov 21
| |||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Gene Therapies Ltd. (SIOX) Snapshot price: $0.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +40.27% | 5.33M |
$3.75 | $19,999,998.75 | 18.58M |
Feb 24
| |||
Form 4
| +6.71% | 6.67M |
$1.50 | $10,000,000.50 | 105.95M |
Mar 18
| |||
Form 4
| +11.20% | 10M |
$1.00 | $10,000,000.00 | 99.29M |
Dec 18
| |||
Form 4
| +19.05% | 14.29M |
$1.75 | $24,999,999.50 | 89.29M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +142.59% | 22.83M |
—
|
—
| 38.85M |
Oct 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||